Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr
about
Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunityBiologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisTocilizumab for rheumatoid arthritisAdverse effects of biologics: a network meta-analysis and Cochrane overviewComparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studyTocilizumabBiologic interventions for fatigue in rheumatoid arthritisFlavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesIs the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritisFatigue in chronic inflammation - a link to pain pathwaysRegulation generation: the suppressive functions of human regulatory T cellsMonoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitorsLipid profile changes in patients with chronic inflammatory arthritis treated with biologic agents and tofacitinib in randomized clinical trials: a systematic review and meta-analysisBiologic agents for rheumatoid arthritis--negotiating the NICE technology appraisalsBlocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementDrug delivery options to increase patient adherence and satisfaction in the management of rheumatoid arthritis -- focus on subcutaneous tocilizumabAdvances in the treatment of rheumatoid arthritis.Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analyRefining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous TocilizumabComparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression AnalysisEffects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseasesGenome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritisBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.[Phase IV non-interventional studies in the treatment of rheumatoid arthritis with biologicals in Germany : real-life clinical practice data].Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data SourcesEffect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor.Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis.Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway functionMatrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsPower Doppler ultrasonography is useful for assessing disease activity and predicting joint destruction in rheumatoid arthritis patients receiving tocilizumab--preliminary data.Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy.Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.
P2860
Q22306446-4347EEE6-8C4E-4D26-B5F4-D215681A8445Q24185797-BBC8BA86-2954-4AEA-8322-8C3477948109Q24234126-8F5AB2EE-97E0-41FB-A305-F06B022DBC28Q24234197-D3A41D60-06C9-435F-AAC1-0DBB2F0FAD61Q24630541-14E8FA51-37C4-43C1-B6F2-8565779A25FCQ24655317-582F9271-6DFE-4B63-8650-DE521BA20DF3Q26471538-E095DF52-FBAB-499F-B3DC-5E0A4F2446D8Q26746303-6179A5F5-486F-4A3E-8C02-43136AB1CEF2Q26746659-E9FF99F2-5D88-4E6C-9EC0-AD0E50A89ECFQ26782282-19ACA866-EB17-4668-85BB-EE20B19D8EE3Q26823216-C9CDFD12-CA5D-4D0B-B7E1-3EDDE6F01331Q26824970-E6A2DBC4-A6CA-4826-A3C5-35DE368FF494Q26859516-D75744E5-BAF1-484A-A954-BA82F43763F9Q27010957-1C9BBD4B-BF88-4BB0-9B0D-4506CA2F05CCQ27021115-4CDEDB7B-6ACA-439E-9964-6EFCDBEBDBA2Q27023091-BAA0B9EB-284D-425F-ACD0-1BAD61245CE9Q27691822-04D7E643-2DA5-4D99-B6A0-8D68EF9AD033Q27694496-DB22A269-7E6E-48C0-85EE-DA857C43A4F0Q28080677-F20182AD-FCFB-487A-B9EE-44ED550DB886Q28547851-A60BD154-45AE-47D7-B26F-61318DD072D2Q28744267-FC7DA0D6-D02F-4942-9EC5-DA695DB27066Q28943301-45C1C600-73DF-4C2E-87D2-42B20D0310EDQ30234528-B9D74D33-525C-4391-83D4-E074FE9461E7Q30235341-C42BD329-0011-408F-A057-E6F3A4B17060Q30612998-B9B4CADC-08E0-4338-9F88-7751DBA2CD73Q30699616-FF9E4207-072E-4E4D-8066-B0BE80A35CBFQ30769719-284637D0-2EB9-4CB0-AB8E-BFB7B1B256AFQ30957102-48EF5D2B-3933-445F-A3FE-87E9EBE551EAQ31137082-428429E3-5925-42C8-A431-7DE776DD1855Q31151183-EB280D86-357E-4BE4-A472-4D34280C2AB7Q33400381-A33C5A8D-9344-4FEC-A67B-77D9C97DB3CBQ33725505-606D70C2-3809-4D55-92DD-CA8FCA924B2FQ33741676-D0D4746B-5A64-4411-AC24-95E998CB4BFAQ33754764-8AD19B05-C215-40E4-A863-A82262B88FFCQ33778719-EF8C5738-68F1-4704-A0FD-1552A61AB0AAQ33802181-798305CE-F1EF-49BF-8018-6FA4830F14AAQ33809045-7B7B4B5F-535B-4200-BFD9-A40D6B3B7692Q33811774-3BF931CF-A3BB-4681-86AD-142D1731BB15Q33921579-1E97AF17-26FA-44C8-BC0D-97BD268E1AD8Q33962865-192760FC-84E2-44AF-ADE4-40391BACD2D3
P2860
Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interleukin-6 receptor inhibit ...... ase-modifying antirheumatic dr
@nl
type
label
Interleukin-6 receptor inhibit ...... ase-modifying antirheumatic dr
@nl
prefLabel
Interleukin-6 receptor inhibit ...... ase-modifying antirheumatic dr
@nl
P2093
P3181
P356
P1476
Interleukin-6 receptor inhibit ...... tirheumatic drug therapy study
@en
P2093
Eduardo F Mysler
Emma Alecock
Evgeny L Nasonov
James D McKay
Juan J Gomez-Reino
Mark C Genovese
Nilzio A da Silva
Thasia Woodworth
P304
P3181
P356
10.1002/ART.23940
P407
P577
2008-10-01T00:00:00Z